loading

Pasithea Therapeutics Corp Azioni (KTTA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
24.21%
2.1487
1.7299 1.51 1.5814 2.358
Operating Income/Loss
3.55%
-3.8109
-3.6802 -3.2596 -3.0046 -3.945
Nonoperating Income/Loss
18.98%
0.0947
0.1169 0.0819 0.00477 0.0788
Income/Loss From Continuing Operations Before Tax
4.29%
-3.7162
-3.5632 -3.1777 -2.9998 -3.8662
Income/Loss From Continuing Operations After Tax
4.29%
-3.7162
-3.5632 -3.1777 -2.9998 -3.8662
Net Income/Loss
4.29%
-3.7162
-3.5632 -3.1777 -2.9998 -3.8662
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
155.12%
5.6413
2.2112 0.0528 1.0441 1.0433
Diluted Average Shares
155.12%
5.6413
2.2112 0.0528 1.0441 1.0433
Basic Earnings Per Share
59.01%
-0.66
-1.61 - - -
Diluted Earnings Per Share
59.01%
-0.66
-1.61 - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$34.92
price down icon 2.39%
$81.44
price down icon 3.18%
$28.68
price down icon 2.58%
$97.88
price down icon 1.88%
$135.83
price down icon 3.62%
biotechnology ONC
$327.37
price down icon 0.64%
Capitalizzazione:     |  Volume (24 ore):